Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
3
×
life sciences
national blog main
national top stories
3
×
new york top stories
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
national
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
allergy
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
anaphylaxis
andrew oxtoby
angelman syndrome
athenex
What
drug
3
×
fda
therapy
3
×
approved
friday
oral
patients
agency
aimmune
allergy
approval
aren’t
atrophy
awarded
bio
daily
developed
developers
drugs
evrysdi
gene
green
help
home
imminent
immunotherapy
intended
late
lights
liquid
long
medicare
medicine
moves
muscular
new
news
noteworthy
peanut
prices
Language
unset
Current search:
fda
×
drug
×
therapy
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More